Cancer, Solid Tumor
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors (NCT02937116) | Innovent Biologics (Suzhou) Co. Ltd. | 2016-10-19 |
| Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) (NCT01295827) | Merck Sharp & Dohme LLC | 2011-03-04 |
Track Cancer, Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.